Demonstration of an abnormality of C apoprotein of very low density lipoprotein in patients with gout

Ann Rheum Dis. 1985 Jun;44(6):390-4. doi: 10.1136/ard.44.6.390.

Abstract

The very low density (VLDL) apolipoproteins of 12 male patients with gout have been studied by analytical isoelectric focusing. The relative percentage distribution of the C apolipoproteins was calculated and compared with that from 12 normolipidaemic and 12 'lipid-matched' controls. In the gout patients apolipoprotein CII (apo CII) represented 19.6% of the VLDL C proteins and the CII/CIII2 ratio was 0.57. In the normolipidaemic controls apo CII represented 28.8% and in the lipid-matched controls 33.1% of VLDL apo C, and the CII/CIII2 ratio approached one in each control group. These differences were significant. This suggests that a reduction in VLDL apo CII may predispose to the hypertriglyceridaemia that is commonly found in patients with gout.

MeSH terms

  • Adult
  • Apolipoprotein C-II
  • Apolipoprotein C-III
  • Apolipoproteins C / blood*
  • Cholesterol / blood
  • Gout / blood*
  • Humans
  • Isoelectric Focusing
  • Lipoproteins, VLDL / blood*
  • Male
  • Middle Aged
  • Triglycerides / blood

Substances

  • Apolipoprotein C-II
  • Apolipoprotein C-III
  • Apolipoproteins C
  • Lipoproteins, VLDL
  • Triglycerides
  • Cholesterol